https://www.selleckchem.com/pr....oducts/SB-203580.htm
he effectiveness and safety profile of fingolimod in real-world setting in the Middle East and North African (MENA) region. Pregnancy among patients with congenital myasthenic syndrome (CMS) is a rare occurrence. Since most of the patients with CMS reach adulthood, questions regarding clinical outcome with pregnancy arise. We describe a 38-year-old Portuguese female who presented in the second trimester of pregnancy with proximal fluctuating limb-girdle weakness, hyperlordosis, waddling gait, dysphagia, dysphonia and ptosis, with no o
Gefällt mir
Kommentar
Teilen
